UAB Newborn Health Research Center
NICHD Neonatal Research Network Clinical Center UAB
This program runs clinical trials and long-term follow-up for newborns—especially very premature or seriously ill infants—so families can access advanced neonatal care and research opportunities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11311371 on NIH RePORTER |
What this research studies
If your baby is cared for in the UAB Level IV NICU, this center enrolls infants into multicenter newborn trials and follow-up studies through the NICHD Neonatal Research Network. The team collects medical information, applies standardized trial treatments when appropriate, and tracks infants’ health and development over time. UAB has high enrollment in network studies and experienced neonatologists who lead and contribute to randomized trials and observational follow-up. If you choose to participate, staff will explain the consent process, study procedures, and schedule follow-up visits to monitor your child.
Who could benefit from this research
Good fit: Newborns admitted to the UAB Level IV NICU—particularly very premature or critically ill infants whose parents can provide consent—are the usual candidates for enrollment.
Not a fit: Healthy full-term babies who do not need NICU care or families unable to travel to UAB are unlikely to be eligible or benefit directly.
Why it matters
Potential benefit: Successful work from this center could give newborns earlier access to improved treatments and better long-term developmental monitoring.
How similar studies have performed: Past Neonatal Research Network trials have produced peer-reviewed, practice-informing results and UAB has been a top enroller in several successful studies.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Carlo Font, Waldemar a. — University of Alabama at Birmingham
- Study coordinator: Carlo Font, Waldemar a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.